New York AI Errors: Who Pays in 2026?

The integration of artificial intelligence into healthcare diagnostics promises unprecedented efficiency, yet the rise of AI diagnostic error in New York presents a complex new frontier for malpractice claims. As AI algorithms increasingly assist medical professionals in interpreting scans, analyzing patient data, and even suggesting diagnoses, the lines of accountability blur when mistakes occur. Who bears responsibility when an algorithm misidentifies a tumor or overlooks a critical condition, leading to patient harm?

Working through the AI Diagnostic Error Field

The adoption of AI in healthcare, particularly in diagnostic imaging and pathology, has been rapid. Hospitals across New York, from Mount Sinai to NewYork-Presbyterian, are exploring or implementing AI tools to enhance diagnostic accuracy and speed. While these technologies offer immense potential, they also introduce novel challenges for patient safety and legal recourse when errors occur. My experience with medical malpractice cases in Georgia has shown that the core principles of negligence still apply, but the evidentiary hurdles in AI cases are distinct.

Case Scenario 1: Delayed Cancer Diagnosis Due to AI Oversight

Consider the case of a 55-year-old retired schoolteacher in Queens County, Ms. Eleanor Vance, who sought treatment for persistent abdominal pain in early 2024. Her primary care physician ordered an abdominal CT scan. The hospital, using a newly implemented AI-powered diagnostic system designed to assist radiologists, processed the scan. The AI algorithm, trained on millions of previous scans, flagged the image as “normal” with a high confidence score, despite a subtle, early-stage pancreatic lesion visible to an experienced human eye. The radiologist, relying heavily on the AI’s output due to high caseloads, concurred with the AI’s assessment.

Hurt by a medical mistake?

Know what your case is worth with AI Medical Payout Calculator for FREE!

Start my free evaluation

Injury Type: Delayed diagnosis of pancreatic cancer, progressing from Stage I to Stage III over eight months. This delay significantly reduced treatment options and prognosis.

Circumstances: The AI system, developed by “MediScan Solutions Inc.” (a fictional entity for illustrative purposes), had a known limitation regarding the detection of early-stage, diffuse lesions, particularly in certain anatomical locations. This limitation was not adequately disclosed in the user manual or during staff training. The radiologist, while in the end responsible, felt pressured by institutional efficiency metrics that encouraged reliance on the AI’s initial findings.

Challenges Faced: Proving that the AI’s failure constituted a deviation from the accepted standard of care was complex. We had to demonstrate not only that a competent human radiologist would have identified the lesion but also that the hospital’s implementation of the AI system was negligent. This involved scrutinizing the AI’s validation process, the training provided to staff, and the hospital’s protocols for human oversight of AI-generated reports. We also faced the defense argument that the radiologist, as the final decision-maker, bore sole responsibility.

Legal Strategy Used: Our strategy focused on a dual-pronged approach: alleging negligence against the hospital for inadequate AI system integration and training, and against the radiologist for failing to exercise independent professional judgment. We engaged expert radiologists to testify on the standard of care for interpreting such scans, even with AI assistance. Importantly, we consulted with AI ethicists and data scientists to dissect the algorithm’s known limitations and the potential for bias in its training data, arguing that the hospital had a duty to understand and mitigate these risks. We invoked principles similar to those found in O.C.G.A. Section 51-1-27, which generally addresses product liability and negligence, adapted to the unique aspects of AI in healthcare.

Settlement/Verdict Amount: The case settled confidentially for a substantial sum in the range of $2.5 million to $4 million after extensive mediation. The settlement reflected the significant reduction in Ms. Vance’s life expectancy and the substantial medical expenses incurred due to the delayed diagnosis.

Timeline: The initial diagnostic error occurred in March 2024. Ms. Vance received a correct diagnosis in November 2024. Legal action commenced in February 2025. The case settled in September 2026, approximately 19 months after filing.

Case Scenario 2: Medication Error Stemming from AI-Assisted EMR

In another instance, Mr. David Chen, a 68-year-old retired electrician from Syracuse, suffered severe kidney damage in late 2025. He was admitted to a central New York hospital for a routine surgical procedure. His electronic medical record (EMR) system incorporated an AI-powered module designed to flag potential drug interactions and contraindications based on patient history. Mr. Chen had a documented allergy to a specific class of antibiotics, which was clearly noted in his EMR. However, the AI module, due to a software glitch or an improperly updated drug database, failed to flag a contraindicated antibiotic prescribed post-surgery.

Injury Type: Acute kidney failure requiring dialysis and a prolonged hospital stay, with permanent kidney function impairment.

Circumstances: The prescribing physician, accustomed to the AI system’s reliability in flagging such issues, did not manually cross-reference the medication against Mr. Chen’s extensive allergy list. The hospital’s pharmacy system, also integrated with the AI module, similarly failed to issue an alert. The error was only discovered days later when Mr. Chen’s condition rapidly deteriorated.

Challenges Faced: Establishing liability involved dissecting the interplay between the AI system, the EMR vendor, the prescribing physician, and the hospital. Was the software vendor responsible for the database error? Was the hospital negligent in its maintenance and oversight of the AI system? Did the physician deviate from the standard of care by overly relying on the AI without independent verification?

Legal Strategy Used: We argued that while AI tools are valuable, they do not absolve human medical professionals of their duty to exercise independent judgment and verify critical information. Our expert testimony highlighted that the standard of care requires physicians to review patient allergies regardless of AI prompts. We also investigated the EMR vendor’s update protocols and the hospital’s internal quality assurance processes for AI-integrated systems. The hospital had a clear policy stating that AI alerts were supplementary and not a substitute for human review, which they failed to enforce. This case drew parallels to product liability claims, where a defective product (the AI module) contributes to injury, but also highlighted the systemic failures within the healthcare provider’s workflow. The New York State Department of Health’s regulations concerning patient safety and electronic health records also played a role in our arguments.

Settlement/Verdict Amount: This case resulted in a settlement of approximately $1.2 million to $2 million. The settlement covered Mr. Chen’s extensive medical bills, lost quality of life, and ongoing dialysis treatments. The EMR vendor and the hospital shared in the settlement.

Timeline: The medication error occurred in October 2025. Mr. Chen was discharged in December 2025. Legal proceedings began in March 2026 and concluded with a settlement in October 2026, roughly seven months after filing.

The Evolving Legal Framework for AI Malpractice

New York, like other states, is grappling with how existing medical malpractice laws apply to AI-driven errors. The core principle remains: did the healthcare provider or system deviate from the accepted standard of care, causing injury? The challenge lies in defining that standard when AI is involved. Is the standard of care for a radiologist using AI the same as one who does not? What constitutes reasonable human oversight of an AI system?

Attorneys pursuing these cases must become adept at understanding the technical aspects of AI, including its training data, algorithms, and validation processes. This often requires collaborating with technical experts, such as computer scientists specializing in machine learning and AI ethics. The American Medical Association (AMA) has issued guidance on the ethical use of AI in medicine, which can be influential in establishing a standard of care. Their principles emphasize human oversight and accountability.

One critical factor is the transparency of the AI system, often referred to as “explainable AI” (XAI). If an AI system makes a diagnostic suggestion, can the medical professional understand the reasoning behind it? A black-box system, where the AI’s decision-making process is opaque, poses greater challenges for accountability. Hospitals and clinics implementing AI have a duty to select and deploy systems that allow for appropriate human review and intervention.

Factor Analysis for AI Malpractice Claims

• Level of Human Oversight: Was the AI’s output merely advisory, or was it treated as definitive? The degree to which a human professional reviewed and validated the AI’s findings is important.
• AI System Validation and Training: Was the AI system adequately tested and validated before deployment? Were its limitations communicated to users?
• Training Data Bias: Did the AI’s training data contain biases that led to inaccurate diagnoses for certain patient demographics? This is a growing concern in AI ethics.
• Software Glitches or Errors: Was the error due to a defect in the AI software itself, potentially opening the door to product liability claims against the developer?
• Adherence to Internal Protocols: Did the hospital or clinic have clear protocols for AI use, and were these protocols followed?
• Severity of Injury: As with all malpractice claims, the extent of patient harm directly impacts the potential settlement or verdict amount.
• Causation: Can a clear causal link be established between the AI error and the patient’s injury? This can be particularly challenging when multiple factors contribute to a diagnostic outcome.

The legal field surrounding AI diagnostic error in New York is still developing. However, the fundamental principles of medical negligence provide a strong foundation for pursuing these claims. Patients who suspect they have been harmed by an AI-related diagnostic error should consult with an attorney experienced in medical malpractice to explore their options.

The complexity of these cases demands a legal team willing to dig into technical details and consult with specialized experts. It is not enough to simply say an AI made a mistake. One must demonstrate how that mistake constituted a deviation from the accepted standard of care, whether by the AI developer, the healthcare facility, or the medical professional.

In the end, the goal is to ensure that technological advancements in healthcare do not come at the expense of patient safety and accountability. As AI continues to integrate into medical practice, the legal system must adapt to protect patients from the unique risks these powerful tools present.

Understanding the interplay of technology, medical practice, and legal precedent is paramount for anyone seeking justice after an AI diagnostic error. Don’t hesitate to seek counsel. Your health and well-being deserve rigorous protection.